Page Nav

HIDE

Grid

GRID_STYLE
latest

non-small-cell lung cancer (NSCLC)

“ This is further sub-divided into squamous cell carcinoma (SCC) (35%), adenocarcinoma (30%) and large-cell carcinoma (15%). Plain film •   ...

This is further sub-divided into squamous cell carcinoma (SCC) (35%), adenocarcinoma (30%) and large-cell carcinoma (15%).
Plain film

•  Lung mass.
•  Lung/lobar collapse denoting an obstructing endobronchial mass.
•  Pleural effusion.
•  SCC tends to cavitate, adenocarcinoma may appear as consolidation resistant to antibiotics.
•  Check for mediastinal or hilar lymph node enlargement and bone destruction.

CT

•  Ill-defined, peripheral, spiculated and irregular nodules are high risk.
•  Air bronchogram and focal lucency in a nodule also suggest malignancy.
•  Cavitation is non-specific, but a cavity wall >15 mm thick is worrying.
•  Nodules enhancing >15 HU are 98% sensitive, 73% specific for malignancy.
•  Common sites for metastases include adrenal glands, liver, brain, bones and soft tissues.

Nuclear medicine
•  PET is superior for staging (92% accuracy, 25% for CT) and assessing bone disease (92% vs. 87%).
•  False positives may arise due to inflammatory processes.